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The RIFLE criteria were developed to improve consistency in
the assessment of acute kidney injury. The high face validity,
collaborative development method, and validation against
mortality have supported the widespread adoption of the
RIFLE to evaluate adult patients; however, its inconsistent
application in adult studies is associated with significant
effects on the estimated incidence of acute kidney injury.
As the RIFLE criteria are now being used to determine acute
kidney injury in children, we conducted a systematic review
to describe its application and assess associations between
the RIFLE and measures of mortality and morbidity in
pediatric patients. In 12 studies we found wide variation
in the application of the RIFLE, including the range of
assessed RIFLE categories, omission of urine output criteria,
varying definitions of baseline renal function, and methods
for handling missing baseline measurements. Limited and
conflicting associations between the RIFLE and mortality,
length of stay, illness severity, and measures of kidney
function were found. Thus, although the RIFLE was
developed to improve the consistency of defining acute
kidney injury, there are still major discrepancies in its use
in pediatric patients that may undermine its potential utility
as a standardized measure of acute kidney injury in children.
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Acute kidney injury (AKI) is a common adverse event in
hospitalized patients, associated with increased mortality,
length of stay (LOS) , and resource utilization.1–4 The use of
over 35 definitions of AKI has contributed to wide variation
in reported incidence rates and has complicated comparisons
between studies.2,5,6 Two main definitions of AKI have been
adopted: the RIFLE6 and the Acute Kidney Injury Network
(AKIN)7 criteria, both based on common markers of kidney
function. Given evidence that the RIFLE captures more mild
cases of AKI than the AKIN8 and the AKIN classification
does not improve outcome prediction over the RIFLE,9,10 the
focus of this review is on the RIFLE definition of AKI.
The RIFLE criteria were developed by an international
consensus panel and are intended for use in critically ill
adults.6 The RIFLE classifies increasing severity of AKI into
five categories: risk (R), injury (I), failure (F), loss of kidney
function (L), and end-stage kidney disease (E). The classi-
fication is based on the magnitude and duration of changes
from the patient’s normal (baseline) kidney function,
assessed by glomerular filtration rate (GFR) and urine
output, and the length of renal replacement therapy (RRT).
When a measure of the patient’s baseline GFR is not available
or is unknown, the panel suggested assuming a GFR of
75 ml/min per 1.73 m2, the lower limit of normal.6
The RIFLE has been widely adopted in adult populations
and is now being used as a ‘gold standard’ to validate new
biomarkers of the kidney function.11 However, a systematic
review of the RIFLE criteria and mortality in adults, which
found increasing RIFLE severity was associated with increas-
ing mortality, revealed that the application of the criteria
was inconsistent.2 Variations in the application of the RIFLE,
particularly in the estimation methods for baseline renal
function, can significantly affect the reported incidence
of AKI.12–14
The RIFLE criteria are now being used to describe AKI
in children and a modification of the RIFLE (the pRIFLE)
has been suggested for use in pediatric populations.15 The
modifications are minor and include a focus on the estimated
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creatinine clearance (eCCl) as the measure of GFR, the
threshold for the ‘Failure’ category from a serum creatinine
X4 mg per 100 ml to an eCCl o35 ml/min per 1.73 m2, and
increasing the time interval for the urine output criteria
to 8 h from 6 h (Table 1). The increasing use of the RIFLE
classification underscores the importance of consistent
application and raises a need to understand whether the
relationships between the RIFLE criteria, and mortality and
morbidity found in adult patients also exist in pediatric
patients. We conducted a systematic review to describe the
application of the RIFLE and to assess associations between
the RIFLE and measures of mortality and morbidity
(specifically LOS and measures of illness severity and kidney
function) in pediatric populations.
RESULTS
The search identified 45 articles, 12 of which met the
inclusion/exclusion criteria8,15–25 (Figure 1). All studies
described the application of the RIFLE criteria in a pediatric
patient population, and 10 (83%) described associations
between the RIFLE, and mortality and morbidity8,15,17–22,24,25
(Table 2). The total number of patients per study ranged
from 2517 to 3396,22 all of whom were hospital inpatients. Six
studies were conducted prospectively;15–18,23,24 the remaining
six were conducted retrospectively.8,19–22,25 The one multi-
center study included 17 centers.18
Patient populations varied and included, for example,
all pediatric intensive care unit (ICU) admissions,22 specific
ICU patients (i.e., those with respiratory and/or cardiac
failure15,21,23,24), and surgical patients.17,19,25 A RIFLE
severity of ‘Risk’ or higher was reported in 10% (ref. 22) to
100% (ref. 18) of patients (Figure 2).
Application of the RIFLE
Four studies (25%) cited using the original RIFLE16,17,19,22
and the remaining eight (75%) referenced the proposed
pediatric modification.8,15,18,20,21,23–25 All studies used the
GFR criteria to define and classify AKI (Table 3) and five used
the GFR criteria in combination with the urine output
criteria.15,18–21 No study relied solely on urine output to
classify AKI. One study (8%) only reported AKI as defined
by a RIFLE category of ‘R’ or higher,17 10 studies (83%)
reported the first three clinical categories (Risk, Injury, and
Failure),8,15,16,19–25 and 1 study (8%) used all of the RIFLE
categories.18
Missing data
In nine studies (75%), it was unclear if patients were
excluded if they were missing data necessary to determine
RIFLE classification and, in the event data were missing, it
was unclear how this was handled.8,15–17,19–22,24 Two studies
purposefully excluded patients: Zappitelli et al.25 stated that
Table 1 | RIFLE criteria and suggested pediatric modification (pRIFLE)
RIFLE6 Modification (pRIFLE)15
GFR criteria
Urine output
criteria GFR criteria
Urine output
criteria
Risk Increased creatinine  1.5 or GFRa decrease 425% o0.5ml/kg/h 6 h eCClb decrease by 25% o0.5ml/kg/h 8 h
Injury Increased creatinine  2 or GFR decrease 450% o0.5ml/kg/h 12 h eCCl decrease by 50% o0.5ml/kg/h 16 h
Failure Increased creatinine  3 or GFR decrease 475%
or creatinine X4mg/dl (acute rise X0.5mg/dl)
o0.3ml/kg/h 24 h
or anuria 12 h
eCCl decrease by 75%
or eCCl o35ml/min
per 1.73m2
o0.3ml/kg/h 24 h
or anuria 12 h
Loss Persistent ARF¼ complete loss of renal function 4 4 weeks (defined as
the need for RRT for 44 weeks)
Persistent failure
44 weeksc
RRT/dialysis
criteria
End-stage End-stage renal disease (defined as the need for dialysis for 43 months) End-stage renal disease
(persistent failure 43 months)c
Abbreviations: ARF, acute renal failure; eCCl, estimated creatinine clearance; GFR, glomerular filtration rate; RRT, renal replacement therapy.
aEstimated using the Modification for Diet in Renal Disease (MDRD) formula; if no baseline measurement available, assign a lower limit of normal GFR of 75ml/min
per 1.73m2.
bEstimated using the Schwartz formula; if no baseline measurement available, assign 100ml/min per 1.73m2.
cThe definitions of persistent failure were not described; it is assumed that they are the same as defined by the original RIFLE.
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Figure 1 | Flow diagram of included and excluded studies.
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patients with no serum creatinine measurements during the
study period were excluded, and Washburn et al.23 excluded
patients with o2 serum creatinine measurements. It is
unlikely that Duzova et al.18 purposefully excluded patients as
they state that only 423 (89.6%) of the 472 patients enrolled
in the study had a RIFLE classification available.
GFR criteria
The GFR criteria were assessed by relative changes in eCCl
(n¼ 8),8,15,16,18,20,21,23,24 changes in serum creatinine
(n¼ 3),17,22,25 or were not specified (n¼ 1).19 Of those that
used eCCl, 7 (88%) specified that the eCCl was calculated
using the Schwartz formula;8,15,16,20,21,23,24 one study did not
specify the estimation method.18 The Schwartz method
requires the patient’s height along with a serum creatinine
measurement.26 No study discussed the availability or
accuracy of height measurements or how the absence of
these data was managed.
Definitions of the baseline measurement of renal function
varied; five studies used creatinine measured within 3 months
of admission or study initiation,8,15,20,21,24 one used the most
recent measure within 6 months of admission,22 and two used
pre-operative serum creatinine measures: one within 1 week
of surgery or the lowest measure available in the month
before surgery,25 the other did not specify the time period.17
Four studies did not specify the baseline definition.16,18,19,23
Missing baseline GFR values were managed as follows: five
assigned values of either 100 ml/min per 1.73 m2 (refs 15,21)
or 120 ml/min per 1.73 m2 (refs 8,20,24) for eCCl. Two
studies used age- and gender-adjusted normal values for
missing baseline creatinine values; one used high-end normal
values,22 and the other used the lower limit of normal.25
Table 2 | Summary of studies
Author Year Population N
Retrospective/
prospective
Single/multi
center
Measures of
association
Ajami16 2010 Pediatric patients referred for diagnostic or interventional catheterization.
Exclusion criteria mentioned, but not defined
80 Prospective Single
Akcan-
Arikan15
2007 PICU patients with respiratory (defined as requiring invasive mechanical
ventilation) and/or cardiac failure (defined as requiring infusions of
vasoactive medications) who had indwelling urinary catheters, excluding
patients with known end-stage renal disease at PICU admission or
were post-renal transplant status
150 Prospective Single |
Dennen17 2010 Children undergoing scheduled first-time cardiopulmonary bypass
for repair of congenital heart disease, excluding those with known
underlying chronic kidney disease, exposure to nephrotoxins within
1 week of surgery, proteinuria, urinary tract infection, diabetes,
unavailable baseline serum creatinine, and inability to obtain consent
25 Prospective Single |
Duzova18 2010 Centers identified any patient with AKI (defined as an absolute increase
in SCr by either 40.3mg/dl or an increase of X50% from baseline or
a GFR decrease X25% from baseline or a reduction in urine output
(o0.5ml/kg for 48 h)) at the time of admission or during treatment
or those who were acutely ill
472 Prospective Multicenter |
Manrique19 2009 Patients undergoing congenital cardiac surgery requiring cardiopulmonary
bypass
395 Retrospective Single |
Palmieri20 2009 Patients with burn injury (TBSA410%) admitted to burn ICU, excluding
non-survivable burns (decision for comfort care on admission),
admission for non-burn diagnosis, or burn size o10%
123 Retrospective Single |
Plotz21 2008 PICU patients with respiratory failure (defined as requiring 44 days
mechanical ventilation)
103 Retrospective Single |
Schneider22 2010 All patients admitted to PICU excluding those with preexisting chronic
renal insufficiency, end-stage renal disease, or admission for renal
transplantation
3396 Retrospective Single |
Washburn23 2008 PICU patients requiring mechanical ventilation and indwelling bladder
catheterization, excluding patients with known end-stage renal disease
at PICU admission or were post-renal transplant status (same as
Akcan-Arikan15). Patients with o2 SCr levels or those with no urine
specimens were also excluded
137 Prospective Single
Zappitelli24 2007 PICU patients requiring mechanical ventilation and indwelling bladder
catheterization, excluding patients with known end-stage renal disease
at PICU admission or those with post-renal transplant status (same as
Akcan-Arikan15)
140 Prospective Single |
Zappitelli25 2009 Patients undergoing open chest surgery excluding patients with no SCr
measured during their ICU stay
390 Retrospective Single |
Zappitelli8 2011 Patients hospitalized in non-intensive care units and received gentamicin,
tobramycin, or amikacin for X5 days, excluding patients with primary
diagnoses of genitourinary or renal disorders at hospital admission
557 Retrospective Single |
Abbreviations: AKI, acute kidney injury; GFR, glomerular filtration rate; ICU, intensive care unit; PICU, pediatric intensive care unit; SCr, serum creatinine; TBSA, total body
surface area.
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Four studies did not specify how missing baseline GFR values
were accounted for,16,18,19,23 and one study excluded patients
with missing baseline values.17
Urine output criteria
Of the five studies that applied the urine output
criteria,15,18–21 only three studies included patients with
indwelling urinary catheters.15,23,24 Urine output was assessed
in 6-h intervals according to the RIFLE in one study;19 four
studies used 8-h intervals, according to the pRIFLE.15,18,20,21
Associations between the RIFLE and measures of mortality
and morbidity
Ten studies assessed the relationships between the RIFLE and
measures of mortality, LOS, and illness severity8,15,17–22,24,25
(Table 4). To maintain consistency and comparability of
results, unadjusted analyses are presented.
Mortality
Six studies evaluated the association between mortality
and RIFLE-assessed AKI.15,18,20–22,24 Two studies showed
that AKI, defined as a RIFLE severity of ‘Risk’ or higher,
was significantly associated with increased mortality;21,22 one
study found this relationship to be borderline significant
(P¼ 0.057).20 Two studies found a nonsignificant relation-
ship when the RIFLE was dichotomized in this manner, but
found significant increases in mortality when using different
cut points (i.e., ‘Injury’ or higher).15,24 Of the four studies
that assessed mortality across RIFLE strata,18,20–22 two
showed significant differences20,22 whereas the other two
studies found no significant difference in mortality rates
across RIFLE categories.18,21
Length of stay
Seven studies evaluated the association between RIFLE-
assessed AKI and LOS;8,15,17,20–22,25 five studies showed that
AKI, defined as ‘Risk’ or higher, was significantly associated
with longer hospital LOS8,15,17,20,25 and longer ICU
stay,17,20,22,25 though two studies showed no significant
relationship with ICU LOS.15,21 Two studies assessed the
relationship between LOS and RIFLE strata, and no signifi-
cant association was found for hospital20 or ICU LOS.20,22
Illness severity
Five studies compared the RIFLE with a total of four vali-
dated illness severity scores.15,20,22,24,25 Three studies reported
associations between the Pediatric Risk of Mortality Score
(PRISM);15,20,24 Akcan-Arikan et al.15 found a nonsignificant
association between a dichotomous measure of AKI and
a significant increase in PRISM scores across RIFLE strata,
whereas Palmieri et al.20 found a significant association
of AKI with PRISM but no significant difference across
RIFLE strata. Zapitelli et al.24 did show that PRISM scores
increased progressively with increasing RIFLE. Pediatric
Index of Mortality (PIM2) scores were higher in patients
presenting with AKI at ICU admission.22 Surgical severity,
as measured by the Aristotle score, was significantly higher
in patients with AKI, but severity according to the Risk
Adjustment in Congenital Heart Surgery (RACHS-1) score
was not associated with RIFLE.25
Five studies assessed the relationship between RIFLE and
length of mechanical ventilation;19–22,25 significantly longer
lengths of mechanical ventilation in patients with AKI were
reported by three studies;20,22,25 the remaining studies found
nonsignificant associations.19,21 No significant difference
across RIFLE categories was found.20
Measures of kidney function
One study compared the RIFLE GFR criteria with the AKIN
measurement for AKI and found a high level of agreement
between the two methods (84.4%).8
Four studies assessed the relationship between RIFLE and
dialysis use.18,21,24,25 Two studies only assessed a dichot-
omous measure of AKI and reported that dialysis use
and RRT are significantly higher in patients with AKI.21,25
The remaining studies both reported an increase in dialysis
use across RIFLE strata, though these trends were not
significant.18,24
Risk of kidney injury
The relationship between use of nephrotoxic medications and
the RIFLE was evaluated in three studies;8,20,25 two studies
showed that patients with AKI were treated significantly
longer with aminoglycosides than patients without AKI.8,25
Palmieri et al.20 found that the proportion of patients treated
with nephrotoxic medications (aminoglycosides or vanco-
mycin) was similar, though nonsignificant, in patients with
and without AKI; however, the proportion significantly
increased with increasing RIFLE severity.
DISCUSSION
We performed a systematic review of the application of the
RIFLE classification of AKI and its association with measures
of mortality and morbidity in pediatric patients. Twelve
studies met our inclusion criteria. Overall, we found that the
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methods used to determine the RIFLE classification were
incompletely described. Only two of the twelve studies
provided sufficient details to confirm that the measurement
of the RIFLE items were consistent with the cited
method.15,21
Second, the application of the individual criteria varied
significantly between studies, including exclusion of the urine
output criteria and differences in the operationalization of
the GFR criteria, baseline GFR definitions, and methods for
estimating missing baseline values. These findings suggest
that pediatric populations may be vulnerable to the same
measurement-induced variability seen in adult populations;2
for example, of the 24 studies included in Ricci et al’s
systematic review on the relationship between the RIFLE and
mortality, only 12 included both the GFR and urine output
criteria to define RIFLE-based AKI. Consistent application of
the RIFLE criteria is crucial to provide a valid estimate of AKI
within the population of interest as the estimated incidence
of AKI can be significantly influenced by various appli-
cations of the criteria.13,14 For example, different methods for
estimating baseline GFR status have been shown to change
the estimated incidence of AKI from 12 to 88% in critically ill
children and from 5 to 43% in noncritically ill children.12 In
addition, heterogeneity in the application of the RIFLE
prevents meaningful comparison of the rates of AKI between
different study populations. The proposed modification to
the RIFLE for use in pediatric populations further adds to
this variability, with limited justification provided for the
changes made to the original RIFLE.15 Modification of
the urine output assessment from a 6-h to 8-h interval may
be illustrative of pragmatic customization of the RIFLE due
to institutional practice or difficulty with measurement accu-
racy. Only 58% of studies utilized the urine output criteria,
perhaps because of the difficulty of timed urine collection
in patients who are not catheterized. Authors may have over-
come logistic challenges by customizing the RIFLE criteria to
better fit with existing clinical data. Although customization
may serve the immediate needs of individual studies, it limits
the advantages of a common measure and may illustrate a
lack of consensus surrounding the application of the RIFLE
in children. This issue is not limited to pediatric populations
as modifications of the RIFLE have also been proposed
for adult patients. For example, Herget-Rosenthal et al.27
proposed that serum cystatin C may be a useful biomarker
to improve the sensitivity of the RIFLE criteria and Tallgren
et al.28 included it within the GFR criteria, when they applied
the RIFLE to assess AKI in patients undergoing open
abdominal aortic surgery. The issue of customization high-
lights the importance of clearly outlining the definitions
and measurement processes used when defining RIFLE-based
AKI.
Third, unlike in adult studies,2 we found inconsistent
relationships between the RIFLE classification and measures
of mortality and morbidity in children. Studies reported
discordant results between increasing RIFLE severity and
mortality, LOS, illness severity, and measures of kidney
function. These discrepancies may be due to sample size
limitations, heterogeneity between the study populations, or
differences in the application of the RIFLE. Sample size is an
obvious limitation given the relative rarity of AKI outcomes,
such as mortality, in pediatric populations. A recent review
focusing on adult studies with a minimum of 1000 patients
Table 4 | Summary of associations between the RIFLE and measures of mortality and morbidity
Akcan-Arikan15 Dennen17 Duzova18 Manrique19 Palmieri20 Plotz21 Schneider22 Zappitelli24 Zappitelli25 Zappitelli8
AKI (RIFLE severity of ‘Risk’ or higher)
Mortality   + + 
Length of stay ICU  + +  + +
Hospital + + + + +
Illness severity PRISM score + +
PIM2 score +
Aristotle score +
RACHS-1 score 
Mechanical ventilation  +  + +
Kidney function AKIN
RRT + +
Risk of injury Nephrotoxic medications  + +
RIFLE categories
Mortality  +  +
Length of stay ICU  
Hospital 
Illness severity PRISM score +  +
PIM2 score
Aristotle score
RACHS-1 score
Mechanical ventilation 
Kidney function AKIN +
RRT  
Risk of injury Nephrotoxic medications +
Abbreviations: AKI, acute kidney injury; AKIN, Acute Kidney Injury Network; ICU, intensive care unit; PIM2, Pediatric Index of Mortality; PRISM, Pediatric Risk of Mortality;
RACHS-1, Risk Adjustment in Congenital Heart Surgery; RRT, renal replacement therapy.
Note: significant association denoted by +; nonsignificant association denoted by . Blank means that this association was not reported.
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showed consistent, significant associations between the
RIFLE and mortality.29 Two studies described their method-
ology in enough detail to determine that they followed the
methodology exactly as cited;15,21 the reported associations
with mortality were not consistent, though both studies
found no significant association between AKI and increased
ICU LOS. Three studies utilized the same patient popu-
lation but were not consistent in their application of the
pRIFLE.15,23,24 Washburn et al.23 did not report any associ-
ations of interest for this review, however, both Akcan-Arikan
et al.15 and Zappitelli et al.24 showed significant increases in
mortality in the patients with AKI as well as significantly
higher PRISM scores with increasing RIFLE severity. From
these limited results, it appears that similar associations are
seen when the RIFLE is applied consistently, and it may be
that differences in RIFLE application do not affect measures
of association within similar patient populations. It should be
noted that as most studies did not capture the full spectrum
of RIFLE severity, we cannot evaluate the associations
between measures of mortality and morbidity within the
highest severity levels of the measure (‘Loss’ and ‘End-stage’).
However, it may be that the long-term observation required
for these grades of AKI severity was not applicable in studies
focused on hospital outcomes. In addition, some of the
variability in the reported associations may be due to several
other confounding factors, such as illness severity. We chose
to only report unadjusted results, as studies did not control
for the same factors and adjusted results were, thus, not
comparable across studies.
Although associations between the RIFLE and measures of
mortality and morbidity are useful, they are not demon-
strative of the RIFLE’s ability to accurately reflect AKI. Thus,
the RIFLE may be a good measure of illness severity, but
may not truly capture the presence of AKI. Ideally, the RIFLE
would be compared with a ‘gold standard’ measure of AKI.
However, unlike chronic kidney disease, no ‘gold standard’
diagnostic test exists for the diagnosis and severity classifica-
tion of AKI; it is based on a combination of patient
symptoms, clinical tests, and clinical judgment. Comparison
of the RIFLE with the AKIN classification confirms these
tools are unsurprisingly correlated,8,12 a comparison limited
in value as both the measures are creatinine-based. Substitute
measures of kidney function have been assessed, such as the
relationship between the RIFLE and RRT.18,21,25 However,
the value of these assessments is limited as the use of RRT is
captured within the RIFLE definition, and non-renal
indications for dialysis also exist.
The widespread adoption of the RIFLE criteria is reflective
of its collaborative development and the pragmatic use of
the most common measurements of renal function: creati-
nine and urine output. The continued use of the RIFLE
classification will be strengthened by a consistent approach
to the application of RIFLE criteria, including the handling
of missing baseline values, the methods used for the GFR
criteria, and the duration over which urine output is
measured. It is likely that the same variability in application
is also prevalent in the use of the AKIN staging of AKI,
though this was outside the scope of this review. Although
customization of the RIFLE may be necessary due to specific
needs of certain populations under study, we suggest that a
clear description of all methodology used to classify RIFLE-
based AKI will allow for easier comparison between studies
and patient populations. Further work is also required to
fully understand the relationship between the RIFLE and the
measures of mortality and morbidity in children.
Overall, our results suggest that the use of the RIFLE to
assess AKI in children supports the concept of a standardized
measure of AKI severity. However, inconsistencies in the
use of the RIFLE have not facilitated the comparison of rates
and outcomes of AKI in children. Although no single
definition or classification of a complex disease such as AKI
will be perfect, a consensus must be reached as to its
operationalization.
MATERIALS AND METHODS
A literature search was conducted in OVID SP MEDLINE and
EMBASE to identify peer-reviewed publications indexed with
kidney injury (or disease) that specifically mentioned the RIFLE
score. The search was restricted to studies involving children
(Appendix 1). Studies that applied the RIFLE as a measure of
AKI were eligible for inclusion. Non-English studies, letters, com-
mentaries, editorials, conference abstracts, and literature reviews
were excluded. Two reviewers (MBS, VA) screened the abstracts
independently to identify eligible studies, and final inclusion was
determined by consensus. If consensus could not be reached, a third
reviewer (CSP) determined eligibility.
For each article, two reviewers (MBS, VA) independently
abstracted data to describe: (1) the study year of publication, study
population (including inclusion and exclusion criteria), number of
children studied, study design, and rationale for inclusion; (2) the
application of the RIFLE: the version of the RIFLE criteria cite (the
original RIFLE or the pRIFLE modification), the criteria used
to determine RIFLE classification, the range of RIFLE categories
reported, and the number and proportion of patients in each
category; (3) how the RIFLE data were measured: the definition of
baseline GFR estimate, and, if applicable, the method for handling
missing baseline values; and (4) associations between the RIFLE
and measures of mortality and morbidity. These included
ICU and hospital mortality and LOS, accepted illness severity
scales or scores, use of mechanical ventilation, other measures of
kidney function (AKIN classification and the use of dialysis or
RRT), and the use of nephrotoxic medications. We did not
consider associations between the RIFLE and novel markers of
renal function.
The number and percentages of manuscripts with each charac-
teristic assessed were tabulated and reported. No measures of asso-
ciation were presented due to significant heterogeneity in both study
design and population.
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Appendix 1 – Search strategy
OVID
1 Renal insufficiency/kidney failure/kidney failure, acute/kidney tubular necrosis, acute/renal insufficiency,
acute/kidney diseases/
94,748
2 (Rifle or prifle).ti,ab. 653
3 1 and 2 204
4 Limit 4 to ‘‘all child (0–18 years)’’ 28
EMBASE
1 Kidney failure/or acute kidney failure/or acute kidney tubule necrosis/or anuria/or kidney cortex
necrosis/or kidney tubule necrosis/or oliguria/or renal osteodystrophy/or uremia/or kidney disease/or
kidney injury/or (renal adj2 insufficien*).mp. or exp kidney function/or exp dialysis/or exp renal
replacement therapy/
363,833
2 (RIFLE or pRIFLE or (risk adj2 injury adj2 failure adj2 loss adj2 end adj2 stage adj2 disease)).ti,ab. 973
3 1 and 2 406
4 Child 1,015,978
5 3 and 4 29
Total number of studies
(excluding duplicates)
45
798 Kidney International (2012) 81, 791–798
or ig ina l a r t i c l e MB Slater et al.: Systematic review of RIFLE application in children
